SciELO - Scientific Electronic Library Online

 
vol.46 número3Modelo de correlación farmacocinético in vitro-in vivo para el aseguramiento de la calidad de medicamentos antirretroviralesDistribución del genotipo Fim-A de Porphyromonas gingivalis entre la población colombiana índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Colombia Médica

versión On-line ISSN 1657-9534

Resumen

DUQUE, Andrés Felipe et al. Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients. Colomb. Med. [online]. 2015, vol.46, n.3, pp.117-121. ISSN 1657-9534.

Introduction: Mutations in the leucine-rich repeat kinase 2 gene (LRRK2 or Dardarin) are considered to be a common cause of autosomal dominant and sporadic Parkinson's disease, but the prevalence of these mutations varies among populations. Objective: To analyzed the frequency of the LRRK2 p.G2019S mutation (c.6055G>A transition) in a sample of Colombian patients. Methods: In the present study we have analyzed the frequency of the LRRK2 p.G2019S mutation in 154 patients with familial or sporadic Parkinson Disease, including early and late onset patients, and 162 normal controls. Results: Our results show occurrence of this mutation in two cases (2/154, 1.3%) with classical Parkinson's signs, and one completely asymptomatic control (1/162, 0.6%). Conclusion: The p.G2019S mutation is not an important causal factor of Parkinson Disease in Colombia having similar frequencies to those reported in other Latin American populations.

Palabras clave : Parkinson's disease; dardarin; LRRK2; p.G2019S mutation; Colombia.

        · resumen en Español     · texto en Inglés     · Español ( pdf ) | Inglés ( pdf )